HCQ withdrawn from multi-country solidarity trial, WHO said (representational)
Geneva, Switzerland:
The World Health Organization said it had decided on Wednesday to stop trials of hydroxychloroquine as a potential treatment for COVID-19 patients, saying it did not reduce the death rate.
Dr Ana Maria Henao Restrepo of the WHO health emergencies program told a virtual press conference in Geneva that the antimalarial drug was being withdrawn from its multi-country solidarity trial on potential treatments .
“The internal evidence from the Solidarity / Discovery trial, the external evidence from the recovery trial and the combined evidence from these large randomized trials, taken together, suggest that hydroxychloroquine – compared to the standard of care in the treatment of COVID hospitalized – 19 patients – does not reduce the mortality of these patients, “she said.
“Based on this analysis and the review of published evidence, the executive group of the Solidarity / Recovery test met twice and we met with all of the key investigators today.
“After deliberation, they concluded that the hydroxychloroquine arm would be stopped from the solidarity test.”
The announcement came two days after the U.S. revoked emergency use authorizations for hydroxychloroquine and chloroquine, two antimalarials favored by President Donald Trump to treat the new coronavirus.
(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)
